Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Becton, Dickinson
Becton, Dickinson to acquire TriPath Imaging
October 13th, 2006
Becton, Dickinson and Company (BD, BDX) has signed a definitive agreement to acquire the 93.5% of the outstanding shares of TriPath Imaging (TPTH) which BD does not currently own, for a cash purchase price of $9.25 per share, or approximately $350 million. The acquisition is expected to be completed by the end of BD's first fiscal quarter 2007 following the satisfaction of the conditions to the closing that include antitrust clearance and other customary conditions, and the requisite approval by the TriPath Imaging shareholders. TriPath Imaging has agreed to use its reasonable best efforts to hold a special meeting of its shareholders, as promptly as practicable, for...
Source: Medicine & Law Weekly (2006-10-13)
|
